{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:54:39Z","timestamp":1785837279175,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"the National Key Research and Development Program","award":["2023YFC2508905"],"award-info":[{"award-number":["2023YFC2508905"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]},{"name":"The Special Project for Discipline Talent Construction of the Second Affiliated Hospital of the Army Medical University has been unveiled and led","award":["2022XKRC001"],"award-info":[{"award-number":["2022XKRC001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-024-01536-4","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T05:53:49Z","timestamp":1735883629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4361-872X","authenticated-orcid":false,"given":"Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongju","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9494-3901","authenticated-orcid":false,"given":"Qin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-2832","authenticated-orcid":false,"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"key":"1536_CR1","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1200\/JCO.2014.55.1564","volume":"32","author":"HD Klepin","year":"2014","unstructured":"Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32:2541\u201352.","journal-title":"J Clin Oncol"},{"issue":"1","key":"1536_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"key":"1536_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36:70\u201387.","journal-title":"Blood Rev"},{"issue":"15","key":"1536_CR4","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1200\/JCO.18.01600","volume":"37","author":"AH Wei","year":"2019","unstructured":"Wei AH, Strickland SA Jr, Hou JZ, Fiedler W, Lin TL, Walter RB, et al. Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: Results from a phase Ib\/II study. J Clin Oncol. 2019;37(15):1277\u201384.","journal-title":"J Clin Oncol"},{"key":"1536_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/14656566.2018.1465562","volume":"19","author":"LC Michaelis","year":"2018","unstructured":"Michaelis LC, Klepin HD, Walter RB. Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia. Expert Opin Pharmacother. 2018;19:865\u201382.","journal-title":"Expert Opin Pharmacother"},{"key":"1536_CR6","unstructured":"NCCN Clinnical practice guidelines in oncology (NCCN guidelines): acute myeloid leukemia version 2.2023 - March 13, 2023"},{"issue":"12","key":"1536_CR7","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345\u201377.","journal-title":"Blood"},{"issue":"10","key":"1536_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/gcc.22191","volume":"53","author":"F Damm","year":"2014","unstructured":"Damm F, Markus B, Thol F, et al. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns. Genes Chromosomes Cancer. 2014;53(10):824\u201332.","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"1536_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1200\/JCO.2010.32.7742","volume":"29","author":"KH Metzeler","year":"2011","unstructured":"Metzeler KH, Maharry K, Radmacher MD, et al. TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a cancer and Leukemia Group B study. J Clin Oncol. 2011;29(10):1373\u201381.","journal-title":"J Clin Oncol"},{"issue":"14","key":"1536_CR10","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1182\/blood-2011-02-339747","volume":"118","author":"W Chou","year":"2011","unstructured":"Chou W, Chou S, Liu C, et al. TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics. Blood. 2011;118(14):3803\u201310.","journal-title":"Blood"},{"issue":"23","key":"1536_CR11","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, et al. Genomic classification and prognosis in acute Myeloid Leukemia. N Engl J Med. 2016;374(23):2209\u201321.","journal-title":"N Engl J Med"},{"key":"1536_CR12","unstructured":"Shaffer LG, Tommerup N, eds. ISCN 2005: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger; 2005."},{"key":"1536_CR13","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u20131719.","DOI":"10.1038\/s41375-022-01613-1"},{"issue":"4","key":"1536_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976;33(4):451\u20138.","journal-title":"Br J Haematol"},{"key":"1536_CR15","unstructured":"Leukemia & Lymphoma Group, Chinese Society of Hematology, Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of adult acute myeloid leukemia (not APL) (2021). Zhonghua Xue Ye Xue Za Zhi. 2021 Aug 14;42(8):617\u2013623."},{"issue":"11","key":"1536_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s11912-023-01450-0","volume":"25","author":"M Zimmer","year":"2023","unstructured":"Zimmer M, Kadia T. Approach to the older Patient with Acute Myeloid Leukemia. Curr Oncol Rep. 2023;25(11):1203\u201311.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"1536_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13045-021-01110-5","volume":"14","author":"AS Mims","year":"2021","unstructured":"Mims AS, Kohlschmidt J, Borate U, et al. A precision medicine classification for treatment of acute myeloid leukemia in older patients. J Hematol Oncol. 2021;14(1):96.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1536_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40164-019-0158-5","volume":"6","author":"J Yu","year":"2020","unstructured":"Yu J, Li Y, Tao Li T, et al. Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia. Exp Hematol Oncol. 2020;6(9):2.","journal-title":"Exp Hematol Oncol"},{"issue":"22","key":"1536_CR19","doi-asserted-by":"publisher","first-page":"8457","DOI":"10.1002\/cam4.3467","volume":"9","author":"RQ Wang","year":"2020","unstructured":"Wang RQ, Chen CJ, Jing Y, Qin JY, Li Y, Chen GF, et al. Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique. Cancer Med. 2020;9(22):8457\u201367.","journal-title":"Cancer Med"},{"issue":"7","key":"1536_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.51","volume":"6","author":"CY Cher","year":"2016","unstructured":"Cher CY, Leung GMK, Au CH, Chan TL, Ma ESK, Sim JPY, et al. Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome. Blood Cancer J. 2016;6(7): e442.","journal-title":"Blood Cancer J"},{"issue":"11","key":"1536_CR21","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s11912-022-01299-9","volume":"24","author":"DC de Leeuw","year":"2022","unstructured":"de Leeuw DC, Ossenkoppele GJ, Janssen JJWM. Older patients with acute Myeloid Leukemia deserve individualized treatment. Curr Oncol Rep. 2022;24(11):1387\u2013400.","journal-title":"Curr Oncol Rep"},{"issue":"21","key":"1536_CR22","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C R\u00f6llig","year":"2015","unstructured":"R\u00f6llig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood. 2015;125(21):3246\u201352.","journal-title":"Blood"},{"issue":"6","key":"1536_CR23","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.canep.2015.10.020","volume":"39","author":"MJ Hossain","year":"2015","unstructured":"Hossain MJ, Xie L. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data. Cancer Epidemiol. 2015;39(6):892\u2013900.","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"1536_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","volume":"11","author":"H Kantarjian","year":"2021","unstructured":"Kantarjian H, Kadia T, DiNardo C, Daver N, Borthakur G, Elias Jabbour E, et al. Acute myeloid leukemia: current progress and future directions. Blood Cancer J. 2021;11(2):41.","journal-title":"Blood Cancer J"},{"issue":"1","key":"1536_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019;133(1):7\u201317.","journal-title":"Blood"},{"issue":"9","key":"1536_CR26","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajh.25198","volume":"93","author":"M Ohanian","year":"2018","unstructured":"Ohanian M, Garcia-Manero G, Levis M, Jabbour E, Daver N, Gautam Borthakur G, et al. Sorafenib combined with 5-azacytidine in older patients with untreated FLT3-ITD Mutated acute Myeloid Leukemia. Am J Hematol. 2018;93(9):1136\u201341.","journal-title":"Am J Hematol"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-024-01536-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-024-01536-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:44:32Z","timestamp":1764917072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-024-01536-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1536"],"URL":"https:\/\/doi.org\/10.1007\/s10238-024-01536-4","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was approved by the medical ethics committee of second affiliated hospital of army medical university, PLA. And it conforms to the provisions of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27"}}